intermediate, high or very high risk MDS in adult patients chronic Myelomonocytic Leukemia - 2 (CMML-2) Acute Myeloid Leukemia (AML) in adult patients unfit for chemotherapy

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Roll-over study for patients who have completed a prior Novartis sponsored sabatolimab (MBG453) study and are judged by the investigator to … Recruitment ended

2024-515281-14-00 4 2023-02-13

Showing 1–1 of 1 trials